Concepedia
Statistics
Publications
4
Citations
198
H-Index
Active since
2016
Affiliations
Queen Mary University of London(Current)
Hammersmith Hospital
Imperial College London
Imperial College Healthcare NHS Trust
Ajithkumar Sukumaran is an author at Queen Mary University of London specializing in oncology, pharmacology, and chemotherapy.
Publications per year
2016–2021
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma
David J. Pinato, Alessio Cortellini, Ajithkumar Sukumaran et al. · BMC Cancer · 2021 · 74 citations · Full text
Pharmacy, Oncology, Pharmacology +17
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study
John Bridgewater, Andre Lopes, Sandra Beare et al. · BMC Cancer · 2016 · 71 citations · Full text
Medicine, Oncology, Pharmacology +15
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study
Sarah P. Blagden, Ivana Rizzuto, Puvan Suppiah et al. · British Journal of Cancer · 2018 · 43 citations · Full text
Medicine, Oncology, Pharmacology +13
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer
Farasat Kazmi, Shibani Nicum, René L. Roux et al. · Clinical Cancer Research · 2021 · 10 citations · Full text
Medicine, Oncology, Pharmacology +17
1–4 of 4